Antiadrenergic agents, centrally acting

WATSON 453 Pill - orange round, 8mm

Pill with imprint WATSON 453 is Orange, Round and has been identified as Guanfacine Hydrochloride 2 mg. It is supplied by Watson Pharmaceuticals.

Guanfacine is used in the treatment of ADHD; High Blood Pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Guanfacine (Guanfacine [ gwahn-fa-seen ])-WATSON 453-2 mg-Orange-Round
Guanfacine (Guanfacine [ gwahn-fa-seen ])-WATSON 453-2 mg-Orange-Round
Guanfacine (Guanfacine [ gwahn-fa-seen ])-WATSON 453-2 mg-Orange-Round
Guanfacine (Guanfacine [ gwahn-fa-seen ])-WATSON 453-2 mg-Orange-Round
Guanfacine (Guanfacine [ gwahn-fa-seen ])-WATSON 453-2 mg-Orange-Round

Guanfacine
Generic Name: guanfacine [ gwahn-fa-seen ]
Imprint: WATSON 453
Strength: 2 mg
Color: Orange
Size: 8.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Antiadrenergic agents, centrally acting
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00591-0453
Inactive Ingredients: Lactose anhydrous, D&C Yellow No. 10, FD&C Red No. 40, Povidone, Stearic acid, Microcrystalline cellulose, Aluminum oxide,
Latest News
Related Drugs